期刊
CELL BIOCHEMISTRY AND BIOPHYSICS
卷 63, 期 3, 页码 191-198出版社
HUMANA PRESS INC
DOI: 10.1007/s12013-012-9355-0
关键词
Trisomy 13; Prognosis; Intensive treatment; Survival; Natural history
资金
- Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [KAKENHI 18790733]
- Dokkyo Medical University [2005-01-5, 2009]
Intensive treatment for newborns with trisomy 13 is controversial because of their lethal prognosis. We report the better life prognosis of patients with trisomy 13 who received intensive treatment. At our hospital, we provided an intensive management to such patients including resuscitation and surgical procedures as required. Herein, we present the results of a retrospective study (1989-2010) of 16 trisomy 13 cases who received an intensive treatment. None was diagnosed to have trisomy 13 before birth; 9 were delivered by C-section and oxygen was administered to all patients during postpartum resuscitation. Mechanical ventilation was used in 9 patients after tracheal intubation and tracheotomy was performed in 2 patients when withdrawing of extubation was difficult. Regarding prognosis, 9 patients died, 3 were referred to another hospital, and 4 were discharged from the hospital. Four and 7 patients died within 7 and 30 days after birth, respectively. Nine patients survived for > 1 month, 7 for > 180 days, and 5 for > 3 years. Median survival for 16 patients was 733 days. The patients who received intensive treatments survived longer compared to the previous data. This study provides useful information concerning genetic counseling, especially from an ethical point of view, before providing intensive management to newborns with trisomy 13.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据